Bio3 Research srl
Patented use of HMGB1 protein for cardiovascular disease and connective tissue regeneration. Key role of HMGB1 confirmed in patients.
Bio3 has 15 patents on the use of the protein HMGB1 for (a) connective tissue regeneration (diabetic foot ulcers, wound healing, cartilage repair and bone regeneration), and (b) treatment of cardiovascular disorders (atherosclerosis, restenosis, arterial stenosis, and vasculitis). Bio3’s products target significant markets with unmet needs. Bio3’s dietary supplement, Biocysan, treats anemia and oxidative stress in chronic kidney disease patients.